However, the relative contributions of subcutaneous and visceral WAT to SAA production are not known, nor has it been determined that WAT-derived SAA contributes to the circulating SAA pool in obesity (105), or whether WAT-derived SAA induces local cytokine production that stimulates hepatic SAA expression. The gene discussed is SAA1; the disease is obesity due to melanocortin 4 receptor deficiency.